NCT05725005View on ClinicalTrials.gov

PET Study of Repeated ASN51 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 26, 2023

Primary Completion Date

April 4, 2023

Study Completion Date

June 8, 2023

Conditions
Healthy
Interventions
DRUG

ASN51

Oral capsule

Trial Locations (1)

Unknown

Hammersmith, London

Sponsors

Lead Sponsor

Asceneuron S.A.

Collaborators (1)

Invicro
All Listed Sponsors
collaborator

Hammersmith Medicines Research

OTHER

collaborator

Invicro

OTHER

lead

Asceneuron S.A.

INDUSTRY

NCT05725005 - PET Study of Repeated ASN51 in Healthy Volunteers | Biotech Hunter | Biotech Hunter